X-linked lymphoproliferative disease: A progressive immunodeficiency

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 657-682

  Morra, M ^a   Howie, D ^a   Grande, M S ^a   Sayos, J ^a   Wang, N ^a   Wu, C ^a   Engel, P ^a   Terhorst, C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

EBV; Lymphocyte; SAP SH2D1A; SLAM; XLP

Indexed keywords

ANTIGEN PRESENTING CELL; CELL INTERACTION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENE ISOLATION; GENE STRUCTURE; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MISSENSE MUTATION; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; X CHROMOSOME LINKED DISORDER;

AGAMMAGLOBULINEMIA; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; CARRIER PROTEINS; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHENOTYPE; PROTEIN CONFORMATION; RESPIRATORY TRACT INFECTIONS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 0035063939     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.657     Document Type: Review

References (105)

1. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)
2. X-linked lymphoproliferative syndrome registry report
3. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies
4. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus
5. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
6. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
7. Activated lymphocytes during acute Epstein-Barr virus infection
8. Epstein-Barr virus strategy in normal and neoplastic B cells
9. Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy
10. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
11. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome
12. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency
13. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis
14. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: Normal EBV-specific HLA-restricted cytotoxicity
15. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function killer cells to kill Epstein-Barr virus-infected cells
16. Defective natural killer cell activation in X-linked lymphoproliferative disease
17. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease
18. Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection
19. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)
20. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
21. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease
22. Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease
23. Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq
24. Mapping the X-linked lymphoproliferative syndrome
25. Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome
26. High-resolution mapping of probes near the X-linked lymphoproliferative disease (XLP) locus
27. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
28. A novel receptor involved in T-cell activation
29. Genomic organization and characterization of murine SAP: The gene coding for X-linked lymphoproliferative disease
30. Potential pathways for regulation of NK and T cell responses: Differential XLP gene product SAP interactions with SLAM and 2B4
31. SH2D1A and SLAM expression in human lymphocytes and derived cell lines
32. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
33. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus (EBV) infection with clinical phenotype and outcome in X-linked lymphoproliferative disease (XLP)
34. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients
35. Common variable immunodeficiency: Clinical and immunological features of 248 patients
36. Hereditary alterations in the immune response: Coexistence of "agammaglobulinemia", acquired hypogammaglobulinemia and selective immunoglobulin deficiency in a sibship
37. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression
38. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene
39. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
40. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A
41. Cell communication: The inside story
42. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: A reappraisal
43. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains
44. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
45. Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains
46. Phosphotyrosine phosphatases with SH2 domains: Regulators of signal transduction
47. Crystal structure of the tyrosine phosphatase SHP-2
48. Structure and function of SH2-domain containing tyrosine phosphatases
49. Protein tyrosine phosphatases in signal transduction
50. Signal transduction by the TCR for antigen
51. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases
52. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
53. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
54. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B
55. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling
56. p62(dok): A constitutively tyrosine-phosphorylated. GAP-associated protein in chronic myelogenous leukemia progenitor cells
57. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
58. The RasGAP-binding protein. p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells
59. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity
60. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3
61. CD84 leukocyte antigen is a new member of the Ig superfamily
62. Molecular cloning, characterization, and chromosomal localization of the mouse homologue of CD84, a member of the CD2 family of cell surface molecules
63. A monoclonal antibody detecting the Ly-9.2 (Lgp-100) cell-membrane alloantigen
64. Physical and genetic linkage of the genes encoding Ly-9 and CD48 on mouse and human chromosomes 1
65. Characterization of a surface membrane molecule expressed by natural killer cells in most inbred mouse strains: Monoclonal antibody C9.1 identifies an allelic form of the 2B4 antigen
66. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
67. Isolation and characterization of cDNA clones for Humly9: The human homologue of mouse Ly9
68. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA3 and OX-45, maps to chromosome 1q21-q23
69. The CD2-subset of the Ig superfamily of cell surface molecules:receptor-ligand pairs expressed by NK and other immune cells
70. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
71. 2B4: An NK cell activating receptor with unique specificity and signal transduction mechanism
72. SLAM and its role in T cell activation and Th responses
73. Signaling lymphocytic activation molecule (SLAM, CDw150) is homophilic but self-associates with very low affinity
74. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes
75. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells
76. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): Differential expression and responsiveness in Th1 and Th2 cells
77. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule
78. Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium
79. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes
80. CDw150 associates with srchomology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis
81. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling
82. Expression of soluble human signaling lymphocytic activation molecule in vivo
83. SLAM (CDw150) is a cellular receptor for measles virus
84. 2B4 functions as a co-receptor in human NK cell activation
85. Gene structure of the murine NK cell receptor 2B4: Presence of two alternatively spliced isoforms with distinct cytoplasmic domains
86. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4
87. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
88. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
89. Identification of the 2B4 molecule as a counter-receptor for CD48
90. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
91. Activating interactions in human NK cell recognition: The role of 2B4-CD48
92. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
93. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors
94. NK cell receptors
95. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4
96. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation
97. Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48)
98. Isolation and characterization of cDNA clones for mouse Ly-9
99. A new mouse lymphoid alloantigen (Lgp100) recognized by a monoclonal rat antibody
100. Ly-9, an alloantigen maker of lymphocyte differentiation
101. B-cell antigens section report
102. Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: Identity with CD84
103. Genomic characterization of CD84 reveals the existence of five isoforms differing in their cytoplasmic domains
104. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
105. Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice